Toward In Vitro Epigenetic Drug Design for Thyroid Cancer: The Promise of PF-03814735, an Aurora Kinase Inhibitor

Sevim Dalva Aydemir,Cemaliye B. Akyerli,Şirin Yüksel,Hilal Keskin,Mustafa Cengiz Yakicier

Toward In Vitro Epigenetic Drug Design for Thyroid Cancer: The Promise of PF-03814735, an Aurora Kinase Inhibitor

2019

Sevim Dalva Aydemir
Cemaliye B. Akyerli
Şirin Yüksel
Hilal Keskin
Mustafa Cengiz Yakicier

Abstract Thyroid cancer (TC) is a very common malignancy worldwide. Chief among the innovative molecular drug targets for TC are epigenetic modifications. Increased telomerase activity in cancer ce...

Keywords:

Cancer research
Bioinformatics
Aurora inhibitor
Thyroid cancer
In vitro
Biology
Drug
Epigenetics
Cancer
Telomerase
Malignancy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations